Remote Site Contract Manager – CTA & Budget Negotiator

Syneos Health, Inc.; North Carolina; Remote; USD 56,000 - 96,000; Full time

Benefits offered by this job

Company car or car allowance

Health benefits (Medical, Dental, Vis）

401k match

Job summary

Syneos Health, Inc. is seeking a Site Contract Specialist/Contract Manager (CM) for Sponsor Dedicated/Remote-U.S. Only.

You will manage CTAs, site budgets, and contract lifecycle, collaborating with sponsors and study teams to drive timely activation and start-up. The role requires strong negotiation, project management, and document-tracking skills, with familiarity in ICH-GCP and clinical trial processes.

Qualifications

• Bachelor’s degree or equivalent experience in a related field.
• Experience independently managing CTAs, amendments, site budgets, and contract lifecycle management.
• Strong understanding of CTA drafting, templates, budgets, and trial start-up processes.
• Proficiency with sponsor/internal trial tracking systems and ICH-GCP knowledge.

Responsibilities

• Review contract language and budgets for completeness and accuracy.
• Maintain internal trackers to support transparency across negotiations.
• Negotiate study budgets within parameters and escalate when needed.
• Lead kickoff meetings and coordinate contract and budget prep with study teams.
• Draft and finalize contracts and related study-startup documents.

Skills

CTA drafting

Contract negotiation

Project management

Budget development

Microsoft Office

Education

Bachelor's degree in Business, Public Health, Life Sciences, or related field

Tools

Clinical trial tracking systems

Microsoft Office Suite

Job description

Syneos Health, Inc. is seeking a Site Contract Specialist/Contract Manager (CM) for Sponsor Dedicated/Remote-U.S. Only.

You will manage CTAs, site budgets, and contract lifecycle, collaborating with sponsors and study teams to drive timely activation and start-up. The role requires strong negotiation, project management, and document-tracking skills, with familiarity in ICH-GCP and clinical trial processes.